Opportunity Information: Apply for W81XWH 10 PCRP PBRA

  • The Dept. of the Army USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Prostate Cancer Population Based Research Award" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420 Military Medical Research and Development.
  • This funding opportunity was created on Mar 2, 2010 and posted on Mar 2, 2010.
  • Applicants must submit their applications by May 26, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $2,900,000.00 to eligible and selected applicants.
  • The number of recipients for this funding is limited to 3 candidate(s).
  • Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
Apply for W81XWH 10 PCRP PBRA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The DoD Prostate Cancer Research Program (PCRP) Population Based Research Award (PBRA) is a Department of the Army funding opportunity focused on high-impact, population-based prostate cancer research. It was redesigned for FY10 after an earlier version (the FY09 Population Based Idea Development Award) received 31 applications and did not recommend any for funding. The FY10 version is meant to better support studies that use large, well-defined patient populations to produce findings that could meaningfully reduce prostate cancer deaths and suffering, especially by generating insights or tools that can only come from statistical analysis at the population level rather than from small clinical or lab-only datasets.

At its core, this award is for research built around a strong prostate-cancer-specific hypothesis that can be tested using rigorous population-based methods. Applicants can propose a range of accepted study designs, including retrospective or prospective population studies, case-control studies, cohort studies, or other epidemiologic and population-science approaches. A key expectation is that the population sample is large enough to achieve statistical significance, and that the application makes it clear the research team has both the statistical expertise and the practical access needed to carry out the analysis. In other words, it is not enough to have an interesting question; the proposal needs to show that the investigators can actually reach or already have the patient population or biospecimens required, in numbers that can support robust conclusions.

The program highlights several research areas that fit well within this mechanism, including biomarkers, predictors of response to therapy, disease aggressiveness, epidemiology, genomics (either germline or somatic), health disparities, molecular genetics, and risk prediction. These topics signal that the DoD is looking for studies that connect real-world patient variation to meaningful outcomes, such as why some tumors become aggressive, which patients respond to particular treatments, how inherited or tumor-acquired genetic changes shape risk, and how disparities across groups affect incidence, treatment, or survival. The intended payoff is research that translates into better prediction, stratification, and decision-making for prostate cancer at scale.

Human subjects research is allowed under this award, but clinical trials are not. The announcement draws a clear line around what it considers a clinical trial: a prospective study that tests an intervention (for example a drug, device, behavioral program, or surgical procedure) in human subjects and measures outcomes. Projects can still involve human subjects, human data, and human anatomical substances, but they must stay on the observational or non-interventional side, such as analyzing existing records and specimens, building risk models, validating biomarkers in cohorts, or studying population-level factors that influence outcomes.

The solicitation also lays out specific elements the Principal Investigator is expected to address directly. First is impact: the application needs to make a credible case that, if successful, the work would substantially accelerate progress toward eliminating death and suffering from prostate cancer. Second is a robust statistical plan: the study must be designed around sound statistical methods, and the team must demonstrate real statistical capability, not just mention it in passing. Third is a human subject plan focused on feasibility: applicants must document access to the population and/or samples and show the ability to recruit or obtain sufficient numbers to support statistically meaningful results. Fourth is preliminary data: feasibility support is required, and any preliminary results should come from the PI or collaborators on the project, reinforcing that the team already has a foundation for executing the work. Fifth is responsiveness: proposals must align with at least one FY10 PCRP overarching challenge and at least one focus area, meaning the study must clearly connect to the program priorities rather than being a generic population study.

Administratively, the opportunity is listed as Funding Opportunity Number W81XWH 10 PCRP PBRA, offered as a discretionary science and technology research and development program under CFDA 12.420 (Military Medical Research and Development). The funding instrument is a cooperative agreement grant, with an estimated total funding amount of $2.9 million and an expectation of about three awards. The eligibility is described as unrestricted, meaning it is broadly open to different types of applicant organizations unless further limited by details in the full announcement. No cost sharing or matching is required. The opportunity was posted March 2, 2010, with an application closing date of May 26, 2010, and an archive date of June 25, 2010. For support, the announcement points applicants to the CDMRP/USAMRAA help contacts for technical access and electronic submission assistance.

FAQs: DoD Prostate Cancer Research Program (PCRP) Population Based Research Award (PBRA)

What is the PBRA funding opportunity?

The Prostate Cancer Research Program (PCRP) Population Based Research Award (PBRA) is a Department of the Army funding opportunity that supports high-impact, population-based prostate cancer research. It is focused on studies that use large, well-defined patient populations to produce findings that could meaningfully reduce prostate cancer deaths and suffering.

Who is offering this grant?

This opportunity is offered under the Department of Defense (DoD), through the Department of the Army, as part of the PCRP.

What is the purpose of the PBRA?

The PBRA is designed to support research built around a strong prostate-cancer-specific hypothesis that can be tested using rigorous population-based methods. The intent is to generate insights or tools that require statistical analysis at the population level (rather than relying only on small clinical datasets or lab-only datasets).

Why was this award redesigned for FY10?

The FY10 PBRA was redesigned after an earlier version (the FY09 Population Based Idea Development Award) received 31 applications and did not recommend any for funding. The FY10 version is intended to better support feasible, high-impact population-based studies.

What types of study designs are allowed?

The opportunity accepts a range of population-based study designs, including retrospective or prospective population studies, case-control studies, cohort studies, and other epidemiologic and population-science approaches, as long as they are appropriate for testing the proposed hypothesis using rigorous population-based methods.

Does the PBRA require a specific kind of hypothesis?

Yes. The research is expected to be organized around a strong, prostate-cancer-specific hypothesis that can be tested using population-based statistical methods.

How important is sample size in this award?

Sample size is a key expectation. The population sample must be large enough to achieve statistical significance, and the application should clearly show that the team can obtain or access the patient population and/or biospecimens in sufficient numbers to support robust conclusions.

Do applicants have to prove access to patients or samples?

Yes. The solicitation emphasizes feasibility and expects applicants to document practical access to the population and/or samples, along with the ability to recruit or obtain enough cases to support statistically meaningful results.

Is statistical expertise required?

Yes. A robust statistical plan is specifically called out, and the team is expected to demonstrate real statistical capability. It is not sufficient to reference statistics in general terms; the study must be designed around sound statistical methods.

What research areas are highlighted as a good fit for PBRA?

The program highlights multiple areas that fit well within this mechanism, including biomarkers, predictors of response to therapy, disease aggressiveness, epidemiology, genomics (germline or somatic), health disparities, molecular genetics, and risk prediction.

Does the PBRA allow research involving human subjects?

Yes. Human subjects research is allowed, and projects may involve human subjects, human data, and human anatomical substances.

Are clinical trials allowed under this award?

No. Clinical trials are not allowed. The announcement defines a clinical trial as a prospective study that tests an intervention (such as a drug, device, behavioral program, or surgical procedure) in human subjects and measures outcomes.

If clinical trials are not allowed, what kinds of human research are appropriate?

Projects should stay observational or non-interventional, such as analyzing existing records and specimens, building risk models, validating biomarkers in cohorts, or studying population-level factors that influence outcomes.

What does the solicitation expect the Principal Investigator (PI) to address?

The PI is expected to directly address several elements in the application: impact (how the work could accelerate progress toward eliminating death and suffering from prostate cancer), a robust statistical plan, a feasibility-focused human subject plan documenting access to populations/samples, preliminary data supporting feasibility, and responsiveness to program priorities.

Is preliminary data required?

Yes. Feasibility support is required, and any preliminary results should come from the PI or collaborators on the project to demonstrate that the team already has a foundation for executing the proposed work.

What does "responsiveness" mean for this opportunity?

Responsiveness means the proposal must align with at least one FY10 PCRP overarching challenge and at least one focus area. The study should clearly connect to the program priorities rather than being presented as a generic population study.

What is the funding mechanism for this award?

The funding instrument is a cooperative agreement grant.

How much funding is available and how many awards are expected?

The estimated total funding amount is $2.9 million, with an expectation of about three awards.

Is cost sharing or matching required?

No. The opportunity states that no cost sharing or matching is required.

Who is eligible to apply?

Eligibility is described as unrestricted, meaning it is broadly open to different types of applicant organizations unless further limited by details in the full announcement.

What is the Funding Opportunity Number for this solicitation?

The Funding Opportunity Number is W81XWH 10 PCRP PBRA.

What CFDA number is associated with this program?

The solicitation is listed under CFDA 12.420 (Military Medical Research and Development).

When was the opportunity posted and what were the key dates?

The opportunity was posted on March 2, 2010. The application closing date was May 26, 2010, and the archive date was June 25, 2010.

Where can applicants get help with technical access or electronic submission?

The announcement directs applicants to CDMRP/USAMRAA help contacts for technical access and electronic submission assistance.

Browse more opportunities from the same agency: Dept. of the Army USAMRAA

Browse more opportunities from the same category: Science and Technology and other Research and Development

Next opportunity: Family Centered Substance Abuse Treatment Grants for Adolescents and their Families

Previous opportunity: Providing Capacity Building Assistance to Governmental and Indigenous Organizations in order to Improve the Delivery of HIV/AIDS Services in the Democratic Republic of Congo Under the President s Emergency Plan for AIDS Relief (PEPFAR)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for W81XWH 10 PCRP PBRA

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (W81XWH 10 PCRP PBRA) also looked into and applied for these:

Funding Opportunity
Office Wide Broad Agency Announcement Microsystems Technology Office Apply for DARPA BAA 10 35

Funding Number: DARPA BAA 10 35
Agency: DARPA Microsystems Technology Office
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Research in Innovative Approaches to Fusion Energy Sciences Apply for DE FOA 0000286

Funding Number: DE FOA 0000286
Agency: Chicago Service Center
Category: Science and Technology and other Research and Development
Funding Amount: $1,700,000
George Mason University Center for Infrastructure Protection Apply for 2010 CIP 06

Funding Number: 2010 CIP 06
Agency: National Institute of Standards and Technology
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
University of Hawaii, Hawaii Open Supercomputing Center Apply for 2010 CIP 08

Funding Number: 2010 CIP 08
Agency: National Institute of Standards and Technology
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
University of Kentucky Firefighter Gear Safety Research Program Apply for 2010 CIP 09

Funding Number: 2010 CIP 09
Agency: National Institute of Standards and Technology
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
University of Maryland Baltimore County Maryland Center of Excellence for Terahertz Science and Application Apply for 2010 CIP 10

Funding Number: 2010 CIP 10
Agency: National Institute of Standards and Technology
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
University of Rhode Island Rhode Island Consortium for Nanoscience and Nanotechnology Apply for 2010 CIP 11

Funding Number: 2010 CIP 11
Agency: National Institute of Standards and Technology
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Agile Delivery of Electrical Power Technology (ADEPT) Apply for DE FOA 0000288

Funding Number: DE FOA 0000288
Agency: Headquarters
Category: Science and Technology and other Research and Development
Funding Amount: $10,000,000
University at Albany (SUNY) New York Center for National Competitiveness in Nanoscale Characterization at the College of Nanoscale Science and Engineering (CNSE) Apply for 2010 CIP 05

Funding Number: 2010 CIP 05
Agency: National Institute of Standards and Technology
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Building Energy Efficiency Through Innovative Thermodevices (BEETIT) Apply for DE FOA 0000289

Funding Number: DE FOA 0000289
Agency: Headquarters
Category: Science and Technology and other Research and Development
Funding Amount: $10,000,000
Gridscale Rampable Intermittently Dispatchable Storage (GRIDS) Apply for DE FOA 0000290

Funding Number: DE FOA 0000290
Agency: Headquarters
Category: Science and Technology and other Research and Development
Funding Amount: $10,000,000
North Dakota State University Advanced Nanomaterials Research Facility Apply for 2010 CIP 04

Funding Number: 2010 CIP 04
Agency: National Institute of Standards and Technology
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
University of Alabama Interdisciplinary Science and Engineering Teaching and Research Corridor Apply for 2010 CIP 01

Funding Number: 2010 CIP 01
Agency: National Institute of Standards and Technology
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
University of Mississippi Medical Center The Mississippi Biotechnology Research Park Apply for 2010 CIP 02

Funding Number: 2010 CIP 02
Agency: National Institute of Standards and Technology
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Mississippi State University Expansion of the Research, Technology and Economic Development Park Apply for 2010 CIP 03

Funding Number: 2010 CIP 03
Agency: National Institute of Standards and Technology
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Prostate Cancer Health Disparity Training Award Apply for W81XWH 10 PCRP HDTA

Funding Number: W81XWH 10 PCRP HDTA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Prostate Cancer Physician Research Training Award Apply for W81XWH 10 PCRP PRTA

Funding Number: W81XWH 10 PCRP PRTA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Prostate Cancer Training Award Apply for W81XWH 10 PCRP PCTA

Funding Number: W81XWH 10 PCRP PCTA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Small Business Innovation Research Program Phase I Solicitation FY 2011 (Release 1) Apply for 10 546

Funding Number: 10 546
Agency: National Science Foundation
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Histology for Interface Stability over Time (HIST) Apply for DARPA BAA 10 32

Funding Number: DARPA BAA 10 32
Agency: DARPA Microsystems Technology Office
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 10 PCRP PBRA", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.